Clinical Trials Directory

Trials / Completed

CompletedNCT02653638

Blood Brain Flow and Exercise

Cerebral Vasodilator Responses in Sedentary and Exercise Trained Humans

Status
Completed
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
80 (actual)
Sponsor
University of Wisconsin, Madison · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Accepted

Summary

Cerebral vasodilator responses to CO2 will be measured in young healthy adults, healthy sedentary older adults, and healthy exercise trained older adults. This variable will be examined before and after administering the cyclooxygenase inhibitor indomethacin, which has been shown to blunt cerebral vasodilator responses. In addition, the investigators will examine these counter-regulatory hemodynamic mechanisms to hypoperfusion caused by indomethacin.

Detailed description

Normal aging reduces cerebral blood flow and cognitive function. Aging also appears to alter functional connectivity within the brain, which is associated with cognitive functioning. Observational studies suggest that regular physical activity is associated with higher cerebral blood flow and improved cognitive function. However, the mechanistic links among regular physical activity and cerebral blood flow with advancing age are unknown. In this context, it is unclear if aging or exercise training status alters the neurovascular coupling of blood flow in the brain. Thus, the overall goal of this study is to examine the age-related changes in cerebral vasodilatory capacity, an important homeostatic mechanism and marker for effective regulation of cerebral perfusion, in order to determine how it is mechanistically linked to cognition. Additionally, the investigators will explore the potential beneficial effect of physical activity on the relationships between cerebral vasodilation and cognition in humans. The research aims are: 1. To determine if cerebral vasodilator responses are affected by age and exercise training status in healthy adults. 2. To compare the effect of cyclooxygenase inhibition on cerebral vasodilator responses in healthy adults. 3. To determine the neurovascular counter-regulatory response to cyclooxygenase inhibition in healthy adults.

Conditions

Interventions

TypeNameDescription
OTHERControl1. Transcranial Doppler 2. Blood Pressure 3. Heart Rate 4. Oxygen Saturation
DRUGIndomethacin1. Transcranial Doppler 2. Blood Pressure 3. Heart Rate 4. Oxygen Saturation

Timeline

Start date
2016-06-01
Primary completion
2019-04-01
Completion
2019-04-01
First posted
2016-01-12
Last updated
2019-12-18

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02653638. Inclusion in this directory is not an endorsement.